These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Treatment of Secondary Chorea: A Review of the Current Literature. Feinstein E; Walker R Tremor Other Hyperkinet Mov (N Y); 2020 Jul; 10():22. PubMed ID: 32775036 [TBL] [Abstract][Full Text] [Related]
4. Deutetrabenazine for tardive dyskinesia and chorea associated with Huntington's disease: a review of clinical trial data. Claassen DO; Philbin M; Carroll B Expert Opin Pharmacother; 2019 Dec; 20(18):2209-2221. PubMed ID: 31613641 [No Abstract] [Full Text] [Related]
5. deutetrabenazine for the treatment of chorea associated with Huntington's disease. Gupta H; Perkins W; Stark C; Kikkeri S; Kakazu J; Kaye A; Kaye AD Health Psychol Res; 2022; 10(5):36040. PubMed ID: 35774908 [TBL] [Abstract][Full Text] [Related]
6. Diagnosis and treatment of chorea syndromes. Hermann A; Walker RH Curr Neurol Neurosci Rep; 2015; 15(2):514. PubMed ID: 25620691 [TBL] [Abstract][Full Text] [Related]
7. Chapter 33: the history of movement disorders. Lanska DJ Handb Clin Neurol; 2010; 95():501-46. PubMed ID: 19892136 [TBL] [Abstract][Full Text] [Related]
8. Deutetrabenazine for the treatment of Huntington's chorea. Bashir H; Jankovic J Expert Rev Neurother; 2018 Aug; 18(8):625-631. PubMed ID: 29996061 [TBL] [Abstract][Full Text] [Related]
9. Review of deutetrabenazine: a novel treatment for chorea associated with Huntington's disease. Dean M; Sung VW Drug Des Devel Ther; 2018; 12():313-319. PubMed ID: 29497277 [TBL] [Abstract][Full Text] [Related]
10. Deep brain stimulation for Huntington's disease: long-term results of a prospective open-label study. Gonzalez V; Cif L; Biolsi B; Garcia-Ptacek S; Seychelles A; Sanrey E; Descours I; Coubes C; de Moura AM; Corlobe A; James S; Roujeau T; Coubes P J Neurosurg; 2014 Jul; 121(1):114-22. PubMed ID: 24702329 [TBL] [Abstract][Full Text] [Related]
11. Tardive dyskinesia: placing vesicular monoamine transporter type 2 (VMAT2) inhibitors into clinical perspective. Citrome L Expert Rev Neurother; 2018 Apr; 18(4):323-332. PubMed ID: 29557243 [TBL] [Abstract][Full Text] [Related]
12. Deutetrabenazine: A Review in Chorea Associated with Huntington's Disease. Heo YA; Scott LJ Drugs; 2017 Nov; 77(17):1857-1864. PubMed ID: 29080203 [TBL] [Abstract][Full Text] [Related]
13. Safety of Converting From Tetrabenazine to Deutetrabenazine for the Treatment of Chorea. Frank S; Stamler D; Kayson E; Claassen DO; Colcher A; Davis C; Duker A; Eberly S; Elmer L; Furr-Stimming E; Gudesblatt M; Hunter C; Jankovic J; Kostyk SK; Kumar R; Loy C; Mallonee W; Oakes D; Scott BL; Sung V; Goldstein J; Vaughan C; Testa CM; JAMA Neurol; 2017 Aug; 74(8):977-982. PubMed ID: 28692723 [TBL] [Abstract][Full Text] [Related]
14. The non-Huntington disease choreas: Five new things. Walker RH Neurol Clin Pract; 2016 Apr; 6(2):150-156. PubMed ID: 29377035 [TBL] [Abstract][Full Text] [Related]
15. A systematic review on treatment of tardive dyskinesia with valbenazine and deutetrabenazine. Patel RS; Mansuri Z; Motiwala F; Saeed H; Jannareddy N; Patel H; Zafar MK Ther Adv Psychopharmacol; 2019; 9():2045125319847882. PubMed ID: 31205680 [TBL] [Abstract][Full Text] [Related]
16. Deep brain stimulation for other tremors, myoclonus, and chorea. Starr PA Handb Clin Neurol; 2013; 116():209-15. PubMed ID: 24112895 [TBL] [Abstract][Full Text] [Related]